TagBand Manual; TagBand Auto
UK Innovations, GP, Ltd. · Decision date Nov 6, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K260608, covering TagBand Manual and TagBand Auto, submitted by UK Innovations, GP, Ltd. The listing carries a decision date of 2026-11-06 and appears in the 510(k) final decisions rendered since October 01, 2026. In 510(k) terms, substantially equivalent means the submission was cleared to market; it is not a PMA approval.
The source record identifies the specialty as Cardiovascular and the product code as DXC, but it does not describe the device's components, materials, intended use, or any specific change from a predicate device. The relationship to any predicate is likewise unstated. Researchers should treat the clearance scope as unknown beyond the listed device names and applicant, and consult the underlying FDA 510(k) record for indications and technical detail.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 6, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260608
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- UK Innovations, GP, Ltd.
- Product code
- DXC
- Decision code
- SESE
- Decision date
- Nov 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Clamp, Vascular.
- Applicant
- UK Innovations, GP, Ltd.
- Product code
- DXC
- FDA device class
- 2
FDA decision timeline
K260608 received
Application receipt date recorded by FDA.
K260608 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
UK Innovations, GP, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- London
Sources and methodology
- Original FDA record: K260608
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records